C2i Genomics
C2i Genomics61
About
What does C2i Genomics do?
C2i Genomics is pioneering the most comprehensive whole-genome monitoring for cancer recurrence and progression. Their technology analyzes subtle changes in the tumor's DNA patterns to provide early detection and personalized treatment monitoring.
What is C2i Genomics's revenue?
StartupHub estimates C2i Genomics's annual revenue at $3.2M (range $2.4M to $6.5M, 64% confidence), based on comparable companies in the sector.
What is C2i Genomics's valuation?
StartupHub estimates C2i Genomics's effective valuation at $453.7M (range $280.0M to $672.0M, 10% confidence), based on comparable companies in the sector.
How much funding has C2i Genomics raised?
C2i Genomics has raised a total of $112M in funding. The most recent round on record is Series B.
Where is C2i Genomics headquartered?
C2i Genomics is headquartered in Tel Aviv, Israel.
When was C2i Genomics founded?
C2i Genomics was founded in 2018.
What industry does C2i Genomics operate in?
C2i Genomics operates in Healthcare, Genomics, Cancer, Tumor Detection, DNA, Liquid Biopsy.
How many employees does C2i Genomics have?
C2i Genomics has approximately 17 people on record.
No comments yet. Be the first to share your take.